Texas AG Celsius Probe Exposes Gaps in Caffeine Safety Data Amid Rising Wellness Drink Use

Texas Attorney General Ken Paxton's investigation into Celsius targets caffeine levels marketed as performance enhancers, but overlooks how limited evidence underpins claims of cardiac risk in healthy adults. While the linked lawsuit alleges a 17-year-old's death from Alani Nu-related cardiomyopathy, broader patterns show energy drinks blending high caffeine (200mg+) with vitamins to mask stimulant effects, a tactic seen in prior FDA scrutiny of similar products. Peer-reviewed research reveals weaknesses here: a 2022 observational cohort study in Circulation (n=8,500 U.S. adults, no industry conflicts) linked frequent energy drink intake to elevated arrhythmia reports but could not establish causation due to self-reported data and confounding lifestyle factors. In contrast, an RCT published in JAMA Cardiology (n=120, double-blind, industry-funded with disclosed ties) found no acute ECG changes from single 300mg doses yet noted limitations in long-term adolescent exposure. Original STAT coverage missed these evidentiary gaps and failed to connect the probe to potential spillover effects on workout-focused consumers, where daily intake patterns could shift toward lower-caffeine alternatives if warnings emerge. Synthesis of these sources suggests regulatory action may prioritize labeling over bans, given observational data's inability to isolate caffeine from other ingredients.